It has been reported that DMG-M is a distinct subtype of isocitrate dehydrogenase (IDH) wild-type glioma (31), and that the co-deletion of IDH and 1p/19q are related to T2-FLAIR mismatch (30, 32, 33). This evidence concerns the gene IDH3A and central nervous system cancer.